Immunogenicity, reactogenicity, and safety of a second booster with BNT162b2 or full-dose mRNA-1273 : a randomized VACCELERATE trial in adults aged ≥75 years (EU-COVAT-1-AGED Part B)
Source
International journal of infectious diseases - ISSN 1201-9712-146 (2024) p. 1-11
Endemic human coronavirus-specific nasal immunoglobulin A and serum immunoglobulin G dynamics in lower respiratory tract infections
Source
Vaccines - ISSN 2076-393X-12:1 (2024) p. 1-9
Immunogenicity and reactogenicity of a first booster with BNT162b2 or full-dose mRNA-1273 : a randomised VACCELERATE trial in adults ≥75 years (EU-COVAT-1)
Source
Vaccine - ISSN 0264-410X-41:48 (2023) p. 7166-7175
Clinical diagnosis of SARS-CoV-2 infection : an observational study of respiratory tract infection in primary care in the early phase of the pandemic
Source
The European journal of general practice - ISSN 1381-4788-29:1 (2023) p. 1-8
Randomized, double-blind, placebo-controlled trial of a throat spray with selected Lactobacilli in COVID-19 outpatients
Source
Microbiology spectrum - ISSN 2165-0497-10:5 (2022) p. 1-14